Condensed Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Jan. 30, 2015	Jan. 24, 2014
OPERATING ACTIVITIES:
Net income (loss)	$ 103,974	$ 53,553
Adjustments to reconcile net income (loss) to net cash (used in)/provided by operating activities:
Depreciation	21,744	26,098
Amortization	2,157	2,044
Stock-based compensation	3,266	5,004
(Gain)/loss on asset divestitures	(47,952)	(2,857)
Changes in certain assets and liabilities, net of effects of acquired businesses:
(Increase)/decrease in accounts and notes receivable	56,656	102,823
(Increase)/decrease in inventories and other assets	(78,469)	(81,254)
Increase/(decrease) in trade accounts payable and other accrued liabilities	(89,009)	(93,130)
Increase/(decrease) in income taxes payable	5,077	407
Increase/(decrease) in other deferred liabilities	3,893	(3,914)
Other	(4,659)	543
Net Cash (Used In)/Provided By Operating Activities	(23,322)	9,317
INVESTING ACTIVITIES:
Purchases of property, plant and equipment	(17,839)	(20,991)
Acquisition of businesses, net of cash acquired	(1,599)	0
Divestiture of businesses	54,552	4,716
Cash proceeds on disposal of assets	650	23
(Increase)/decrease in restricted cash	148	309
Net Cash (Used In)/Provided By Investing Activities	35,912	(15,943)
FINANCING ACTIVITIES:
Proceeds from issuance of debt	500,000	0
Payments of debt	(113,938)	(25,016)
Net change in borrowings	3,987	2,106
Net proceeds (repayments) of commercial paper	(234,894)	93,419
Proceeds from Stock Options Exercised	3,189	1,588
Treasury stock purchases	(83,582)	(69,178)
Excess tax benefit from stock-based compensation	7,768	5,154
Dividends paid	(24,574)	(22,226)
Net Cash (Used In)/Provided By Financing Activities	57,956	(14,153)
Increase/(Decrease) in Cash and Cash Equivalents	70,546	(20,779)
Effect of exchange rate changes on Cash and Cash Equivalents	(6,983)	(2,780)
Cash and Cash Equivalents at Beginning of Period	128,203	216,150
Cash and Cash Equivalents at End of Period	$ 191,766	$ 192,591